Spring sale! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ads free!Spring sale! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ads free today!Spring sale! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
US
Politics
World
Sports
Business
Crypto
Entertainment
Lifestyle
Tech
Science

Teva
Pharmaceuticals
GSK
Johnson & Johnson
Novo Nordisk
AstraZeneca
Pfizer
Sanofi
Eli Lilly
Merck and Co
Valneva
Topics

Advertisement

Teva

Share

Top Latest Popular

In the last 4 hours

Teva v. Lilly: Conflicting Positions at PTAB and District Court Sink Patent Challenge JD Supra 19:10

Yesterday

Movement Disorder Tardive Dyskinesia Webpage Launched By Nonprofit Rural Minds AgriMarketing 08:03 Thu, 07 May

Corcept Must Face Most Teva Mifepristone Antitrust Claims Law360 03:39 Thu, 07 May

Advertisement

Advertisement

Wednesday

Teva Ruling Keeps Drug-Monopoly Lawsuit Alive Against Corcept Bloomberg Law 21:50 Wed, 06 May

Federal Circuit Reverses JMOL of Invalidity of Teva’s Ajovy® Patents JD Supra 16:59 Wed, 06 May

Tuesday

Teva, US Argue Over Drug Definitions in Medicare Price Cut Suit Bloomberg Law 19:25 Tue, 05 May

Is It Too Late To Reassess Teva Pharmaceutical Industries (TEVA) After Its Strong Multi Year Rally? Simply Wall St 19:01 Tue, 05 May

Saturday

Two Setups, One Framework: What eBay and Teva Reveal About Trade Selection Barchart 20:28 Sat, 02 May

The Mandalorian & Grogu Movie: New Photo May Spoil a Major Star Wars Cameo The Direct 16:35 Sat, 02 May

In the last month

What Teva v. Eli Lilly Means for Written Description and Enablement of Method-of-Use Patents JD Supra 20:24 Thu, 30 Apr

TEVA Q1 Earnings Top Estimates, Branded Drugs Drive Revenues, Stock Up Zacks 16:21 Thu, 30 Apr

Teva Locks In Tourette’s Frontrunner With $700m Emalex Buy Scrip Pharma Intelligence 15:12 Thu, 30 Apr

Teva makes its first M&A play in years, buying Emalex pharmaphorum 12:54 Thu, 30 Apr

Teva signs off $900m Emalex buyout amid strategic pipeline boosting ploy Pharmaceutical Technology 11:27 Thu, 30 Apr

Advertisement

A Look At Teva (TEVA) Valuation After Strong Q1 2026 Earnings And Biosimilar Pipeline Progress Simply Wall St 11:05 Thu, 30 Apr

Blackstone's $400 Million Bet on Teva: What Does the Smart Money Know That Most Investors Don't? The Motley Fool 10:09 Thu, 30 Apr

The deal that signals Teva is back CTech 10:04 Thu, 30 Apr

Teva Acquires Tourette's Drugmaker For Up To $900M Law360 21:43 Wed, 29 Apr

With Austedo at helm, Teva's impressive innovative drug sales signal company's successful metamorphosis FiercePharma 20:19 Wed, 29 Apr

Teva Signals Confidence With $700 Million Pipeline Push, Buyback Plan Benzinga 19:02 Wed, 29 Apr

Teva Pharmaceutical Industries (TEVA) Reports Q1 Earnings: What Key Metrics Have to Say Zacks 17:04 Wed, 29 Apr

DBEF, SPOT, TEVA, NBIS: ETF Outflow Alert Nasdaq 16:14 Wed, 29 Apr

Teva Lowers 2026 Non-GAAP Operating Profit Outlook On Emalex Deal; On Track To Achieve 2027 Targets RTT News 13:19 Wed, 29 Apr

Teva beats estimates but cuts profit outlook after Emalex deal CTech 13:06 Wed, 29 Apr

Teva acquires Emalex Biosciences for up to $900m Globes 13:02 Wed, 29 Apr

Teva Acquires Emalex Biosciences, Expands Neuroscience Pipeline RTT News 12:31 Wed, 29 Apr

Teva to acquire Emalex in deal worth up to $900 million CTech 12:05 Wed, 29 Apr

Teva v. Lilly: Limiting Amgen’s Reach on Written Description and Enablement JD Supra 20:26 Tue, 28 Apr

Teva v. Lilly -- Clarifies Written Description of Method Claims Involving A Genus JD Supra 17:31 Tue, 28 Apr

How Does Orange Book Delisting Affect Ongoing Hatch-Waxman Litigation? JD Supra 16:40 Tue, 28 Apr

Teva’s Home Ground Schizophrenia Push And What It Could Mean For Investors Simply Wall St 10:56 Tue, 28 Apr

Teva Pharmaceutical's Turnaround Is Working. Here's When to Buy the Stock. The Motley Fool 03:03 Tue, 28 Apr

Federal Circuit Clarifies Written Description and Enablement Standards for Method-of-Treatment Patent Claims Using a Well-Known... JD Supra 20:45 Mon, 27 Apr

Federal Circuit Reverses JMOL and Reinstates Jury Verdict in Teva v. Lilly JD Supra 18:31 Mon, 27 Apr

Teva honored for gender equality as women reach 43% of senior management in Israel Jerusalem Post 09:36 Mon, 27 Apr

I spent 2 weeks running in the Teva Aventrail trail sandals – it's not as crazy as it sounds Woman and Home 19:00 Fri, 24 Apr

Relaxing the Rules: How Claim Type Supported Patent Validity for Teva Pharmaceuticals’ “Headache Patents” JD Supra 17:37 Wed, 22 Apr

Fed Circuit hands headache patent win back to Teva BioWorld 21:51 Tue, 21 Apr

Broad Antibody Method of Treatment Claims Upheld by Federal Circuit JD Supra 20:01 Tue, 21 Apr

Teva Pharmaceuticals International v. Eli Lilly & Co. (Fed. Cir. 2026) JD Supra 20:01 Mon, 20 Apr

Advertisement

Advertisement

Teva News

NewsNow brings you the latest news from the world’s most trusted sources on Teva. NewsNow aims to be the world’s most accurate and comprehensive Teva news aggregator, bringing you the latest headlines automatically and continuously 24/7.

News Now

Our Sites

News Now Nigeria

News Now România

News Now Italia

News Now Canada

News Now Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Shire Shire
- Takeda Takeda
- Teva Teva
- Valneva Valneva
- Zoetis Zoetis